Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2012

Open Access 01-12-2012 | Research

Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma

Authors: Bo Bae Choi, Sung Hun Kim, Bong Joo Kang, Ji Hye Lee, Byung Joo Song, Seung Hee Jeong, Hyeon Woo Yim

Published in: World Journal of Surgical Oncology | Issue 1/2012

Login to get access

Abstract

Background

FDG PET/CT and DWI are both functional modalities that indirectly represent the biological characteristics of cancer, but there are few studies exploring the association between the two modalities and prognostic factors. Our study attempted to evaluate the mutual association by comparing the prognostic factors, SUVmax value of PET/CT, and ADC values associated with diffusion imaging in invasive ductal carcinoma (IDC) patients.

Methods

Patients with pathologically confirmed IDC were recruited. There were 118 patients who underwent MRI, including DWI, FDG PET/CT, and immunohistochemical staining of the surgical specimen. Histologic analysis was done on tumor size, lymph node metastasis, expression of estrogen receptors (ER), progesterone receptors (PR), human epidermal growth factor receptor 2 (HER2), Ki-67, and epidermal growth factor receptors (EGFR). The relationship among ADC values, SUVmax and prognostic factors were evaluated.

Results

There was significant association between the ADC value and ER-positive and HER2-negative expression. Significant associations were noted between SUVmax and tumor size, lymph node metastasis, histologic grade, ER and PR expression, EGFR and Ki-67. However, there was no significant correlation between the ADC value and SUVmax.

Conclusions

Even though there was no correlation between ADC and SUVmax, both indexes are useful for predicting the prognosis of IDC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nakajo M, Kajiya Y, Kaneko T, Kaneko Y, Takasaki T, Tani A, Ueno M, Koriyama C, Nakajo M: FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging. 2010, 37: 2011-2020. 10.1007/s00259-010-1529-7.CrossRefPubMed Nakajo M, Kajiya Y, Kaneko T, Kaneko Y, Takasaki T, Tani A, Ueno M, Koriyama C, Nakajo M: FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging. 2010, 37: 2011-2020. 10.1007/s00259-010-1529-7.CrossRefPubMed
2.
go back to reference Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H, Shishikura T, Imazeki K, Nakajima N: Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro [18 F]-D-glucose. Cancer. 1998, 82: 2227-2234. 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W.CrossRefPubMed Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H, Shishikura T, Imazeki K, Nakajima N: Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro [18 F]-D-glucose. Cancer. 1998, 82: 2227-2234. 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W.CrossRefPubMed
3.
go back to reference Ikenaga N, Otomo N, Toyofuku A, Ueda Y, Toyoda K, Hayashi T, Nishikawa K, Tanaka M: Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors. Am Surg. 2007, 73: 1151-1157.PubMed Ikenaga N, Otomo N, Toyofuku A, Ueda Y, Toyoda K, Hayashi T, Nishikawa K, Tanaka M: Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors. Am Surg. 2007, 73: 1151-1157.PubMed
4.
go back to reference Kim SH, Cha ES, Kim HS, Kang BJ, Choi JJ, Jung JH, Park YG, Suh YJ: Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging. 2009, 30: 615-620. 10.1002/jmri.21884.CrossRefPubMed Kim SH, Cha ES, Kim HS, Kang BJ, Choi JJ, Jung JH, Park YG, Suh YJ: Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors. J Magn Reson Imaging. 2009, 30: 615-620. 10.1002/jmri.21884.CrossRefPubMed
5.
go back to reference Ho KC, Lin G, Wang JJ, Lai CH, Chang CJ, Yen TC: Correlation of apparent diffusion coefficients measured by 3 T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging. 2009, 36: 200-208. 10.1007/s00259-008-0936-5.CrossRefPubMed Ho KC, Lin G, Wang JJ, Lai CH, Chang CJ, Yen TC: Correlation of apparent diffusion coefficients measured by 3 T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer. Eur J Nucl Med Mol Imaging. 2009, 36: 200-208. 10.1007/s00259-008-0936-5.CrossRefPubMed
6.
go back to reference Jeh SK, Kim SH, Kim HS, Kang BJ, Jeong SH, Yim HW, Song BJ: Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging. 2011, 33: 102-109. 10.1002/jmri.22400.CrossRefPubMed Jeh SK, Kim SH, Kim HS, Kang BJ, Jeong SH, Yim HW, Song BJ: Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma. J Magn Reson Imaging. 2011, 33: 102-109. 10.1002/jmri.22400.CrossRefPubMed
7.
go back to reference Razek AA, Gaballa G, Denewer A, Nada N: Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed. 2010, 23: 619-623. 10.1002/nbm.1503.CrossRefPubMed Razek AA, Gaballa G, Denewer A, Nada N: Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed. 2010, 23: 619-623. 10.1002/nbm.1503.CrossRefPubMed
8.
go back to reference Hatakenaka M, Soeda H, Yabuuchi H, Matsuo Y, Kamitani T, Oda Y, Tsuneyoshi M, Honda H: Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci. 2008, 7: 23-29. 10.2463/mrms.7.23.CrossRefPubMed Hatakenaka M, Soeda H, Yabuuchi H, Matsuo Y, Kamitani T, Oda Y, Tsuneyoshi M, Honda H: Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci. 2008, 7: 23-29. 10.2463/mrms.7.23.CrossRefPubMed
9.
go back to reference Kuroki-Suzuki S, Kuroki Y, Nasu K, Nawano S, Moriyama N, Okazaki M: Detecting breast cancer with non contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci. 2007, 6: 21-27. 10.2463/mrms.6.21.CrossRefPubMed Kuroki-Suzuki S, Kuroki Y, Nasu K, Nawano S, Moriyama N, Okazaki M: Detecting breast cancer with non contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci. 2007, 6: 21-27. 10.2463/mrms.6.21.CrossRefPubMed
10.
go back to reference Patterson DM, Padhani AR, Collins DJ: Technology insight: water diffusion MRI - a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol. 2008, 5: 220-233.CrossRefPubMed Patterson DM, Padhani AR, Collins DJ: Technology insight: water diffusion MRI - a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol. 2008, 5: 220-233.CrossRefPubMed
11.
go back to reference Park SH, Moon WK, Cho N, Chang JM, Im SA, Park IA, Kang KW, Han WS, Noh DY: Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol. 2012, 22: 18-25. 10.1007/s00330-011-2236-x.CrossRefPubMed Park SH, Moon WK, Cho N, Chang JM, Im SA, Park IA, Kang KW, Han WS, Noh DY: Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol. 2012, 22: 18-25. 10.1007/s00330-011-2236-x.CrossRefPubMed
12.
go back to reference Tsushima Y, Takahashi-Taketomi A, Endo K: Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging. 2009, 30: 249-255. 10.1002/jmri.21854.CrossRefPubMed Tsushima Y, Takahashi-Taketomi A, Endo K: Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging. 2009, 30: 249-255. 10.1002/jmri.21854.CrossRefPubMed
13.
go back to reference Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C: Qualitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. Eur Radiol. 2007, 17: 2646-2655. 10.1007/s00330-007-0621-2.CrossRefPubMed Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C: Qualitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions. Eur Radiol. 2007, 17: 2646-2655. 10.1007/s00330-007-0621-2.CrossRefPubMed
14.
go back to reference Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH: The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol. 2007, 8: 390-396. 10.3348/kjr.2007.8.5.390.PubMedCentralCrossRefPubMed Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH: The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol. 2007, 8: 390-396. 10.3348/kjr.2007.8.5.390.PubMedCentralCrossRefPubMed
15.
go back to reference Guo Y, Cai Y, Cai Z, Gao YG, An NY, Ma L, Mahankali S, Gao JH: Differentiation of clinically benign and malignant breast lesions using diffusion weighted imaging. J Magn Reson Imaging. 2002, 16: 172-178. 10.1002/jmri.10140.CrossRefPubMed Guo Y, Cai Y, Cai Z, Gao YG, An NY, Ma L, Mahankali S, Gao JH: Differentiation of clinically benign and malignant breast lesions using diffusion weighted imaging. J Magn Reson Imaging. 2002, 16: 172-178. 10.1002/jmri.10140.CrossRefPubMed
16.
go back to reference Makkat S, Luypaert R, Stadnik T, Bourgain C, Sourbron S, Dujardin M, De Greve J, De Mey J: Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings-preliminary results. Radiology. 2008, 249: 471-482. 10.1148/radiol.2492071147.CrossRefPubMed Makkat S, Luypaert R, Stadnik T, Bourgain C, Sourbron S, Dujardin M, De Greve J, De Mey J: Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings-preliminary results. Radiology. 2008, 249: 471-482. 10.1148/radiol.2492071147.CrossRefPubMed
18.
go back to reference Ali SH, O’Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P: Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res. 2000, 60: 7094-7098.PubMed Ali SH, O’Donnell AL, Balu D, Pohl MB, Seyler MJ, Mohamed S, Mousa S, Dandona P: Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res. 2000, 60: 7094-7098.PubMed
19.
go back to reference Ludovini V, Sidoni A, Pistoloa L, Bellezza G, De Angelis V, Gori S, Mosconi AM, Bisagni G, Cherubini R, Bian AR, Rodinò C, Sabbatini R, Mazzocchi B, Bucciarelli E, Tonato M, Colozza M: Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stage I and II breast cancer patients. Breast Cancer Res Treat. 2003, 81: 159-168. 10.1023/A:1025755717912.CrossRefPubMed Ludovini V, Sidoni A, Pistoloa L, Bellezza G, De Angelis V, Gori S, Mosconi AM, Bisagni G, Cherubini R, Bian AR, Rodinò C, Sabbatini R, Mazzocchi B, Bucciarelli E, Tonato M, Colozza M: Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stage I and II breast cancer patients. Breast Cancer Res Treat. 2003, 81: 159-168. 10.1023/A:1025755717912.CrossRefPubMed
20.
go back to reference Black R, Prescott R, Bers K, Hawkins A, Stewart H, Forrest P: Tumor cellularity, oestrogen receptors and prognosis in breast cancer. Clin Oncol. 1983, 9: 311-318.PubMed Black R, Prescott R, Bers K, Hawkins A, Stewart H, Forrest P: Tumor cellularity, oestrogen receptors and prognosis in breast cancer. Clin Oncol. 1983, 9: 311-318.PubMed
21.
go back to reference Woodhams R, Matsunaga K, Iwabuchi K, Kan S, Hata H, Kuranami M, Watanabe M, Hayakawa K: Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr. 2005, 29: 644-649. 10.1097/01.rct.0000171913.74086.1b.CrossRefPubMed Woodhams R, Matsunaga K, Iwabuchi K, Kan S, Hata H, Kuranami M, Watanabe M, Hayakawa K: Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr. 2005, 29: 644-649. 10.1097/01.rct.0000171913.74086.1b.CrossRefPubMed
22.
go back to reference Yoshikawa MI, Ohsumi S, Sugata S, Kataoka M, Takashima S, Mochizuki T, Ikura H, Imai Y: Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med. 2008, 26: 222-226. 10.1007/s11604-007-0218-3.CrossRefPubMed Yoshikawa MI, Ohsumi S, Sugata S, Kataoka M, Takashima S, Mochizuki T, Ikura H, Imai Y: Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med. 2008, 26: 222-226. 10.1007/s11604-007-0218-3.CrossRefPubMed
23.
go back to reference Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK: Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol. 1999, 17: 2334-2340.PubMed Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK: Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol. 1999, 17: 2334-2340.PubMed
24.
go back to reference Mussurakis S, Buckley DL, Horsman A: Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology. 1997, 203: 317-321.CrossRefPubMed Mussurakis S, Buckley DL, Horsman A: Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. Radiology. 1997, 203: 317-321.CrossRefPubMed
25.
go back to reference Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H: Clinicopathological and prognostic relevance of uptake level using 18 F-fluodeoxyglucose positron emission tomography/computed tomography fusion imaging (18 F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol. 2008, 38: 250-258. 10.1093/jjco/hyn019.CrossRefPubMed Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H: Clinicopathological and prognostic relevance of uptake level using 18 F-fluodeoxyglucose positron emission tomography/computed tomography fusion imaging (18 F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol. 2008, 38: 250-258. 10.1093/jjco/hyn019.CrossRefPubMed
26.
go back to reference Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, Molthoff CF: Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 2002, 20: 379-387. 10.1200/JCO.20.2.379.CrossRefPubMed Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, Molthoff CF: Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 2002, 20: 379-387. 10.1200/JCO.20.2.379.CrossRefPubMed
27.
go back to reference Ito K, Kato T, Ohta T, Tadakoro M, Yamada T, Ikeda M, Masanari N, Ishigaki T, Ito K, Gambhir S: Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity. Eur J Nucl Med. 1996, 23: 1372-1377. 10.1007/BF01367594.CrossRefPubMed Ito K, Kato T, Ohta T, Tadakoro M, Yamada T, Ikeda M, Masanari N, Ishigaki T, Ito K, Gambhir S: Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity. Eur J Nucl Med. 1996, 23: 1372-1377. 10.1007/BF01367594.CrossRefPubMed
Metadata
Title
Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma
Authors
Bo Bae Choi
Sung Hun Kim
Bong Joo Kang
Ji Hye Lee
Byung Joo Song
Seung Hee Jeong
Hyeon Woo Yim
Publication date
01-12-2012
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-126

Other articles of this Issue 1/2012

World Journal of Surgical Oncology 1/2012 Go to the issue